Here, we further determine the relevance of clinically employed gene signatures in the advanced breast cancer (ABC) setting.<b>Experimental Design:</b> Sufficient RNA for expression profiling was obtained from distant metastatic or inoperable loco-regional relapse tissue by fine-needle aspiration from 109 patients of the Swedish TEX clinical trial.